Reports for PFIZER CANADA ULC

Company Name

PFIZER CANADA ULC

Totals

Shortage reports

740

Actual shortage: 84 (11%)
Anticipated shortage: 7 (1%)
Avoided shortage: 48 (6%)
Resolved: 601 (81%)

Discontinuation Reports

84

To be discontinued: 1 (1%)
Discontinued: 82 (98%)
Reversed: 1 (1%)

Late reports

17 (2%)

Overdue reports

9 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATIVAN 0.5MG TABLET Actual shortage 2023-11-17 2024-03-26 210709
ATIVAN 1MG TABLET Anticipated shortage 2023-11-17 2024-04-08 210722
ATIVAN 2MG TABLET Actual shortage 2023-11-17 2024-04-26 210735
BREVICON 1/35 TABLETS (28-DAY PACK) 0.035MG 1MG TABLET Resolved 2023-12-19 2024-03-20 213856
MEDROL 4 MG 4MG TABLET Actual shortage 2023-12-20 2024-04-24 213920
ARTHROTEC 50 200MCG 50MG TABLET (DELAYED-RELEASE) Resolved 2023-01-11 2023-02-17 180648
ARTHROTEC 50 200MCG 50MG TABLET (DELAYED-RELEASE) Actual shortage 2024-04-04 2024-04-15 224337
SALAZOPYRIN EN-TABS 500 MG 500MG TABLET (ENTERIC-COATED) Resolved 2021-03-17 2021-04-16 135852
SALAZOPYRIN EN-TABS 500 MG 500MG TABLET (ENTERIC-COATED) Resolved 2022-10-21 2023-02-16 172396
SALAZOPYRIN EN-TABS 500 MG 500MG TABLET (ENTERIC-COATED) Resolved 2022-10-21 2023-04-05 172399
PRISTIQ 100MG TABLET (EXTENDED-RELEASE) Resolved 2020-01-07 2020-01-31 102502
TOVIAZ 8MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-08 2021-04-01 135301
TOVIAZ 8MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-07 2022-10-01 158318
TOVIAZ 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-11 2022-06-15 160353
PRISTIQ 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-12 2023-03-25 177970
PRISTIQ 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-12 2023-03-21 177973
PRISTIQ 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-09-23 195945
PRISTIQ 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-10-13 195948
DUAVIVE 0.45MG 20MG TABLET (IMMEDIATE AND EXTENDED RELEASE) Resolved 2020-05-13 2023-06-27 114978
DOSTINEX 0.5MG TABLET / TABLETTE Resolved 2017-03-13 2017-04-28 2039

Showing 721 to 740 of 740

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LIDOCAINE HYDROCHLORIDE INJECTION USP 20MG SOLUTION Discontinued 2019-03-28 2019-03-28 79705
EPHEDRINE SULFATE INJECTION USP 50MG SOLUTION Discontinued 2019-03-29 2019-03-30 79932
CYTARABINE INJECTION 100MG SOLUTION Discontinued 2019-09-24 2019-09-25 94589
MITOXANTRONE INJECTION USP 2MG SOLUTION Discontinued 2020-07-30 2020-07-31 121379
FLUOROURACIL INJECTION USP 50MG SOLUTION Discontinued 2020-09-29 2022-01-17 125282
MIDAZOLAM INJECTION 5MG SOLUTION Discontinued 2020-10-07 2020-10-08 125896
MIDAZOLAM INJECTION 5MG SOLUTION Discontinued 2020-10-07 2021-05-01 125899
MIDAZOLAM INJECTION 5MG SOLUTION Reversed 2020-10-07 2020-10-19 125902
MIDAZOLAM INJECTION 1MG SOLUTION Discontinued 2020-10-19 2021-02-02 126640
LIDOCAINE HYDROCHLORIDE INJECTION USP 20MG SOLUTION Discontinued 2021-03-29 2021-03-29 136528
ZOLEDRONIC ACID FOR INJECTION 4MG SOLUTION Discontinued 2021-04-16 2021-04-17 137600
DOXORUBICIN 2MG SOLUTION Discontinued 2021-08-24 2021-08-25 144561
ATROPINE SULFATE INJECTION USP 0.5MG SOLUTION Discontinued 2021-09-07 2021-09-08 145250
DOXORUBICIN 2MG SOLUTION Discontinued 2021-09-07 2021-09-07 145256
IRINOTECAN 20MG SOLUTION Discontinued 2022-06-03 2022-06-04 161820
CIPROFLOXACIN INJECTION USP 2MG SOLUTION Discontinued 2022-09-27 2022-09-28 170299
CIPROFLOXACIN INJECTION USP 2MG SOLUTION Discontinued 2022-09-27 2022-10-01 170302
ROPIVACAINE HYDROCHLORIDE INJECTION USP 10MG SOLUTION Discontinued 2022-09-30 2022-10-02 170496
ROPIVACAINE HYDROCHLORIDE INJECTION USP 10MG SOLUTION Discontinued 2022-09-30 2022-10-02 170499
ROPIVACAINE HYDROCHLORIDE INJECTION USP 5MG SOLUTION Discontinued 2022-09-30 2022-10-02 170502

Showing 41 to 60 of 84